137 related articles for article (PubMed ID: 25300679)
1. Modulation of cGMP accumulation by adenosine A1 receptors at the hippocampus: influence of cGMP levels and gender.
Serpa A; Sebastião AM; Cascalheira JF
Eur J Pharmacol; 2014 Dec; 744():83-90. PubMed ID: 25300679
[TBL] [Abstract][Full Text] [Related]
2. The combined inhibitory effect of the adenosine A1 and cannabinoid CB1 receptors on cAMP accumulation in the hippocampus is additive and independent of A1 receptor desensitization.
Serpa A; Correia S; Ribeiro JA; Sebastião AM; Cascalheira JF
Biomed Res Int; 2015; 2015():872684. PubMed ID: 25667928
[TBL] [Abstract][Full Text] [Related]
3. Tonic adenosine A1 and A2A receptor activation is required for the excitatory action of VIP on synaptic transmission in the CA1 area of the hippocampus.
Cunha-Reis D; Fontinha BM; Ribeiro JA; Sebastião AM
Neuropharmacology; 2007 Feb; 52(2):313-20. PubMed ID: 17030044
[TBL] [Abstract][Full Text] [Related]
4. The Role of cGMP on Adenosine A 1 Receptor-mediated Inhibition of Synaptic Transmission at the Hippocampus.
Pinto I; Serpa A; Sebastião AM; Cascalheira JF
Front Pharmacol; 2016; 7():103. PubMed ID: 27148059
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotection induced by adenosine A1 receptor agonists in a cardiac cell ischemia model involves cooperative activation of adenosine A2A and A2B receptors by endogenous adenosine.
Urmaliya VB; Church JE; Coupar IM; Rose'Meyer RB; Pouton CW; White PJ
J Cardiovasc Pharmacol; 2009 May; 53(5):424-33. PubMed ID: 19333129
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide-induced adenosine inhibition of hippocampal synaptic transmission depends on adenosine kinase inhibition and is cyclic GMP independent.
Arrigoni E; Rosenberg PA
Eur J Neurosci; 2006 Nov; 24(9):2471-80. PubMed ID: 17100836
[TBL] [Abstract][Full Text] [Related]
7. Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium.
Kemeny-Beke A; Jakab A; Zsuga J; Vecsernyes M; Karsai D; Pasztor F; Grenczer M; Szentmiklosi AJ; Berta A; Gesztelyi R
Pharmacol Res; 2007 Aug; 56(2):124-31. PubMed ID: 17574432
[TBL] [Abstract][Full Text] [Related]
8. Influence of metabotropic glutamate receptor agonists on the inhibitory effects of adenosine A1 receptor activation in the rat hippocampus.
de Mendonça A; Ribeiro JA
Br J Pharmacol; 1997 Aug; 121(8):1541-8. PubMed ID: 9283686
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Kumari M; Cover PO; Poyser RH; Buckingham JC
Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
[TBL] [Abstract][Full Text] [Related]
10. A1 and A2A receptor activation by endogenous adenosine is required for VIP enhancement of K+ -evoked [3H]-GABA release from rat hippocampal nerve terminals.
Cunha-Reis D; Ribeiro JA; Sebastião AM
Neurosci Lett; 2008 Jan; 430(3):207-12. PubMed ID: 18054436
[TBL] [Abstract][Full Text] [Related]
11. ATP and its metabolite adenosine act synergistically to mobilize intracellular calcium via the formation of inositol 1,4,5-trisphosphate in a smooth muscle cell line.
Gerwins P; Fredholm BB
J Biol Chem; 1992 Aug; 267(23):16081-7. PubMed ID: 1322890
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide mediates interactions between GABAA receptors and adenosine A1 receptors in the rat hippocampus.
Fragata IR; Ribeiro JA; Sebastião AM
Eur J Pharmacol; 2006 Aug; 543(1-3):32-9. PubMed ID: 16831416
[TBL] [Abstract][Full Text] [Related]
13. Modulating effect of adenosine deaminase on function of adenosine A1 receptors.
Sun WC; Cao Y; Jin L; Wang LZ; Meng F; Zhu XZ
Acta Pharmacol Sin; 2005 Feb; 26(2):160-5. PubMed ID: 15663892
[TBL] [Abstract][Full Text] [Related]
14. Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist.
Heitman LH; Mulder-Krieger T; Spanjersberg RF; von Frijtag Drabbe Künzel JK; Dalpiaz A; IJzerman AP
Br J Pharmacol; 2006 Mar; 147(5):533-41. PubMed ID: 16444290
[TBL] [Abstract][Full Text] [Related]
15. C-Jun N-terminal kinase regulates adenosine A1 receptor-mediated synaptic depression in the rat hippocampus.
Brust TB; Cayabyab FS; MacVicar BA
Neuropharmacology; 2007 Dec; 53(8):906-17. PubMed ID: 17967469
[TBL] [Abstract][Full Text] [Related]
16. Forskolin and 3-isobutyl-1-methylxanthine increase basal and sodium nitroprusside-elevated cyclic GMP levels in adult guinea-pig cerebellar slices.
Hernández F; Alexander SP; Kendall DA
J Neurochem; 1994 Jun; 62(6):2212-8. PubMed ID: 7514648
[TBL] [Abstract][Full Text] [Related]
17. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
Haynes JM; Alexander SP; Hill SJ
Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels.
Merkel LA; Lappe RW; Rivera LM; Cox BF; Perrone MH
J Pharmacol Exp Ther; 1992 Feb; 260(2):437-43. PubMed ID: 1310735
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin inhibition of cyclic AMP accumulation in D384 astrocytoma cells. Evidence against a role of cyclic GMP.
Altiok N; Fredholm BB
Neurochem Int; 1992 Sep; 21(2):209-13. PubMed ID: 1284620
[TBL] [Abstract][Full Text] [Related]
20. Adenosine A1 receptor activation inhibits basal accumulation of inositol phosphates in rat hippocampus.
Cascalheira JF; Sebastião AM
Pharmacol Toxicol; 1998 Apr; 82(4):189-92. PubMed ID: 9584333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
